The more selective amiselimod (S1PR1, S1PR4, S1PR5), ozanimod (S1PR1, S1PR5), and cenerimod (S1PR1) were also shown to confer efficacy and improve renal parameters in murine SLE [111, 113, 116]. The gene discussed is S1PR5; the disease is systemic lupus erythematosus.